Clinical and molecular features of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma: Results in a multi‐center trial
Guardado en:
Autores principales: | Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou, Li Ping Su, Zhuo Wen Chen, Jie Ping Chen, Mei Yun Fang, Ting Liu, Yong Ping Song, Kang Yu, Yan Li, Jian Gu, Ming Hou, Wei Li Zhao, Jian da Hu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ff8da4769dd43f597d48e669b270e6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis
por: Chen-xing Zhao, et al.
Publicado: (2021) -
Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
por: Akiko Hashimoto, et al.
Publicado: (2021) -
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
por: Shaodong Hong, et al.
Publicado: (2019) -
Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.
por: Shu-Jen Chen, et al.
Publicado: (2010) -
Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
por: Miriam Verdu-Bou, et al.
Publicado: (2021)